
Kiora Pharmaceuticals Inc
KPRXNasdaqCIK 1372514HealthcareFiscal year ends Dec 31
Reports and events: 268 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-11-0606:05 ET | 8-K | 9.01 Financial statements and exhibits | 0001372514-23-000154 |
| 2023-09-2819:06 ET | 8-K | 5.07 Shareholder vote results | 0001372514-23-000132 |
| 2023-09-2107:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001372514-23-000129 |
| 2023-09-0107:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001372514-23-000125 |
| 2023-08-0807:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001372514-23-000118 |
| 2023-08-0807:13 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001372514-23-000117 |
| 2023-08-0107:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001372514-23-000112 |
| 2023-07-2116:49 ET | DEF 14A | Proxy statementPeriod 2023-08-31 | 0001372514-23-000110 |
| 2023-07-2017:01 ET | 8-K | 3.01 Delisting notice | 0001372514-23-000107 |
| 2023-06-2116:25 ET | 8-K | 5.07 Shareholder vote results | 0001372514-23-000103 |
| 2023-06-1516:59 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001372514-23-000101 |
| 2023-06-0616:52 ET | 8-K | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001372514-23-000097 |
| 2023-06-0118:01 ET | S-1/A | Registration statement, amended | 0001372514-23-000085 |
| 2023-05-1217:03 ET | S-1/A | Registration statement, amended | 0001628280-23-017953 |
| 2023-05-0907:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001372514-23-000070 |
| 2023-05-0906:59 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001372514-23-000069 |
| 2023-05-0517:01 ET | S-1 | Registration statement | 0001628280-23-016198 |
| 2023-04-2814:16 ET | DEF 14A | Proxy statementPeriod 2023-06-21 | 0001372514-23-000059 |
| 2023-04-2714:55 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001372514-23-000057 |
| 2023-03-3007:02 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001372514-23-000053 |
| 2023-03-2307:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001372514-23-000051 |
| 2023-03-2307:01 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001372514-23-000050 |
| 2023-02-0707:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001372514-23-000010 |
| 2023-02-0317:21 ET | S-1 | Registration statement | 0001104659-23-010675 |
| 2023-02-0307:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001372514-23-000008 |
| 2023-01-0916:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-002295 |
| 2023-01-0316:31 ET | 8-K | 8.01 Other events | 0001104659-23-000363 |
| 2022-12-2219:30 ET | S-1 | Registration statement | 0001104659-22-129237 |
| 2022-11-2107:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-120486 |
| 2022-11-0906:04 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001410578-22-003035 |
| 2022-10-1306:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-108263 |
| 2022-09-2606:45 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-102816 |
| 2022-09-2316:30 ET | 8-K | 5.07 Shareholder vote results | 0001104659-22-102697 |
| 2022-09-1616:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-100852 |
| 2022-08-2516:33 ET | 8-K | 3.01 Delisting notice | 0001104659-22-094445 |
| 2022-08-1517:56 ET | DEF 14A | Proxy statementPeriod 2022-09-23 | 0001104659-22-091303 |
| 2022-08-1206:18 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001410578-22-002336 |
| 2022-08-0816:30 ET | DEF 14A | Proxy statementPeriod 2022-09-15 | 0001104659-22-087273 |
| 2022-08-0416:36 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-22-086182 |
| 2022-07-2616:31 ET | 8-K | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-082802 |
| 2022-07-2119:23 ET | S-1/A | Registration statement, amended | 0001104659-22-081271 |
| 2022-07-1917:14 ET | S-1/A | Registration statement, amended | 0001104659-22-080880 |
| 2022-07-1317:24 ET | S-1/A | Registration statement, amended | 0001104659-22-079591 |
| 2022-07-0817:00 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001410578-22-001934 |
| 2022-07-0717:34 ET | 10-K/A | Annual report, amendedPeriod 2021-12-31 | 0001410578-22-001931 |
| 2022-06-2117:19 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-22-073063 |
| 2022-05-3116:30 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-22-066571 |
| 2022-05-2316:30 ET | 8-K | 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits | 0001104659-22-063871 |
| 2022-05-0316:38 ET | S-1 | Registration statement | 0001104659-22-055297 |
| 2022-04-2606:51 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-22-049935 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:43 ET. Listed shows no prices and gives no investment advice.